Latest / Health & Veritas: Yale's Healthcare and Health Policy Podcast
Dr. Utibe Essien: Who Gets Access to Innovative Treatments?
Harlan reports on a new study testing the effectiveness of the OCD drug fluvoxamine in treating COVID; Howie reflects on the potential of continuous glucose monitoring for people with diabetes. And they're joined by Dr. Utibe Essien of the University of Pittsburgh to discuss the barriers preventing people of color from getting innovative new treatments and medications.
Links:
"Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial"
Utibe Essien: "Association of Neighborhood Disadvantage and Anticoagulation for Patients with…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.